BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34612668)

  • 1. Improved Sample Preparation for Untargeted Metabolomics Profiling of Escherichia coli.
    Ye D; Li X; Wang C; Liu S; Zhao L; Du J; Xu J; Li J; Tian L; Xia X
    Microbiol Spectr; 2021 Oct; 9(2):e0062521. PubMed ID: 34612668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative metabolomics shows the metabolic profiles fluctuate in multi-drug resistant Escherichia coli strains.
    Lin Y; Li W; Sun L; Lin Z; Jiang Y; Ling Y; Lin X
    J Proteomics; 2019 Sep; 207():103468. PubMed ID: 31374362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive proteomic and metabolomic profiling of mcr-1-mediated colistin resistance in Escherichia coli.
    Li H; Wang Y; Meng Q; Wang Y; Xia G; Xia X; Shen J
    Int J Antimicrob Agents; 2019 Jun; 53(6):795-804. PubMed ID: 30811973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.
    Hoerr V; Duggan GE; Zbytnuik L; Poon KK; Große C; Neugebauer U; Methling K; Löffler B; Vogel HJ
    BMC Microbiol; 2016 May; 16():82. PubMed ID: 27159970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metabolomics-based method for studying the effect of yfcC gene in Escherichia coli on metabolism.
    Wang X; Xie Y; Gao P; Zhang S; Tan H; Yang F; Lian R; Tian J; Xu G
    Anal Biochem; 2014 Apr; 451():48-55. PubMed ID: 24513124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontargeted Metabolomics Reveals the Multilevel Response to Antibiotic Perturbations.
    Zampieri M; Zimmermann M; Claassen M; Sauer U
    Cell Rep; 2017 May; 19(6):1214-1228. PubMed ID: 28494870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative Alterations of Bacterial Metabolome after Exposure to Metal Nanoparticles with Bactericidal Properties: A Comprehensive Workflow Based on (1)H NMR, UHPLC-HRMS, and Metabolic Databases.
    Chatzimitakos TG; Stalikas CD
    J Proteome Res; 2016 Sep; 15(9):3322-30. PubMed ID: 27432757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinnamaldehyde Characterization as an Antibacterial Agent toward E. coli Metabolic Profile Using 96-Blade Solid-Phase Microextraction Coupled to Liquid Chromatography-Mass Spectrometry.
    Mousavi F; Bojko B; Bessonneau V; Pawliszyn J
    J Proteome Res; 2016 Mar; 15(3):963-75. PubMed ID: 26811002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics-Driven Exploration of the Chemical Drug Space to Predict Combination Antimicrobial Therapies.
    Campos AI; Zampieri M
    Mol Cell; 2019 Jun; 74(6):1291-1303.e6. PubMed ID: 31047795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic efficacy is linked to bacterial cellular respiration.
    Lobritz MA; Belenky P; Porter CB; Gutierrez A; Yang JH; Schwarz EG; Dwyer DJ; Khalil AS; Collins JJ
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8173-80. PubMed ID: 26100898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untargeted Metabolomics To Ascertain Antibiotic Modes of Action.
    Vincent IM; Ehmann DE; Mills SD; Perros M; Barrett MP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2281-91. PubMed ID: 26833150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR metabolomic analysis of bacterial resistance pathways using multivalent quaternary ammonium functionalized macromolecules.
    Aries ML; Cloninger MJ
    Metabolomics; 2020 Jul; 16(8):82. PubMed ID: 32705355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS/MS-based metabolic profiling of Escherichia coli under heterologous gene expression stress.
    Nadeem MS; Razeeth M; Choudhry HMZ; Anwar F; Zamzami MA; Murtaza BN; Al-Abbasi FAM; Khan MI; Shakoori AR
    J Cell Biochem; 2020 Jan; 121(1):125-134. PubMed ID: 31232490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Solid-Phase Microextraction-Liquid Chromatography-Mass Spectrometry for Microbial Untargeted Metabolomics.
    Mousavi F; Bojko B; Pawliszyn J
    Methods Mol Biol; 2019; 1859():133-152. PubMed ID: 30421227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic identification of metabolites controlling gene expression in E. coli.
    Lempp M; Farke N; Kuntz M; Freibert SA; Lill R; Link H
    Nat Commun; 2019 Oct; 10(1):4463. PubMed ID: 31578326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bias caused by incomplete metabolite extraction and matrix effect: Evaluation of critical factors for plasma sample preparation prior to metabolomics.
    Liao HW; Cheng YW; Tang SC; Kuo CH
    J Pharm Biomed Anal; 2022 Sep; 219():114930. PubMed ID: 35839581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteome analysis of an antibiotic resistant Escherichia coli exposed to tetracycline reveals multiple affected metabolic and peptidoglycan processes.
    Jones-Dias D; Carvalho AS; Moura IB; Manageiro V; Igrejas G; Caniça M; Matthiesen R
    J Proteomics; 2017 Mar; 156():20-28. PubMed ID: 28043878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative proteomics and metabolomics approach to elucidate the antimicrobial effect of simvastatin on Escherichia coli.
    Kocak E; Nemutlu E; Kır S; Sagıroglu M; Özkul C
    Biomed Chromatogr; 2021 Oct; 35(10):e5180. PubMed ID: 34043824
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.